Browse studies

Find your next paid study

3,222 recruiting studies matching your filters

A Randomized, Double-Blind, Placebo-Controlled Pilot Study to Evaluate the Anti-Inflammatory and Healthy Aging Effects of AppleX™ Apple Extract (15% Fisetin) in Adults 45-70 Years of Age

The goal of this clinical trial is to learn if AppleX™ Apple Extract can help lower systemic inflammation in adults aged 45-70 with signs of low-grade inflamma…

Systemic Inflammation (hsCRP)Healthy AgingVitality+1 more

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Nutraland USA, Inc.NCT07678346

Myasthenia Gravis Foundation of America Global MG Patient Registry

The goal of this observational study is to learn about the experiences of people living with Myasthenia Gravis (MG) in the United States. The main questions it…

Myasthaenia GravisMyastheniaMyasthenia Gravis Associated with Thymoma+10 more

Estimated

~$10 – $750

Actual pay is set by the research site.

Myasthenia Gravis Foundation of AmericaNCT06617741

Observational

Evaluating the Effectiveness of Remote Monitoring for Post-Operative Management of Distal Radius Fractures: A Randomized Controlled Trial

This randomized controlled trial evaluates whether remote monitoring can provide a safe and effective alternative to traditional in-person follow-up after surg…

Distal Radius FractureDistal Radius Fracture Fixation

Estimated

~$10 – $750

Actual pay is set by the research site.

University of Missouri-ColumbiaNCT07219979

Phase 2

High Precision Stereotactic Radiotherapy to the Whole Prostate With Focal Boost and Varying Hormonal Therapy (HEATWAVE)

This phase II trial evaluates apalutamide in combination with image-guided stereotactic body radiation therapy (SBRT) for the treatment of patients with prosta…

Prostate AdenocarcinomaStage II Prostate Cancer AJCC v8Stage IIIA Prostate Cancer AJCC v8+1 more

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Jonsson Comprehensive Cancer CenterNCT06067269

Phase 1

An Open-Label, Multicenter Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of XL309 (ISM3091) as Single-Agent and Combination Therapy in Patients With Advanced Solid Tumors

This is a first-in-human (FIH), multicenter, open-label Phase I study to investigate the safety, tolerability, preliminary antitumor activity, as well as pharm…

Advanced Solid Tumor

Estimated

~$150 – $4,500

Actual pay is set by the research site.

ExelixisNCT05932862

Sample Collection for Ongoing Research and Product Evaluation (SCORE) Study

The SCORE study is a prospective, multi-site clinical trial designed to collect blood and tissue samples, along with relevant clinical data, from participants …

Breast CancerLung CancerMuscle Invasive Bladder Cancer+9 more

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Natera, Inc.NCT07318051

Phase 2

A Randomized Trial Comparing Early Local Chemoradiation Therapy +/- Surgery Versus Systemic Therapy for Patients With Esophageal or Gastric Cancer With Oligometastases

This phase II trial studies how well chemotherapy with or without radiation or surgery works in treating participants with esophageal or gastric cancer that ha…

Gastric AdenocarcinomaOligometastasisStage IV Esophageal Adenocarcinoma AJCC v7+2 more

Estimated

~$75 – $2,000

Actual pay is set by the research site.

M.D. Anderson Cancer CenterNCT03161522

Phase 3

A Phase 3, Randomized Study to Evaluate the Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-Grade Non-Muscle Invasive Bladder Cancer

The goal of this clinical trial is to learn if TARA-002 can treat high-grade non-muscle invasive bladder cancer (NMIBC) in BCG-naïve adults 18 years of age or …

Bladder (Urothelial, Transitional Cell) CancerNon-Muscle Invasive Bladder CarcinomaNon-muscle Invasive Bladder Cancer With Carcinoma in Situ

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Protara TherapeuticsNCT07480356

Phase 1

A Phase Ib/II Study of Axatilimab in Combination With Retifanlimab and Paclitaxel for the Treatment of Patients With Advanced Solid Tumors

This phase I/II trial tests the safety, side effects, and effectiveness of axatilimab in combination with retifanlimab and paclitaxel for the treatment of pati…

Advanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmRecurrent Malignant Solid Neoplasm+1 more

Estimated

~$150 – $4,500

Actual pay is set by the research site.

OHSU Knight Cancer InstituteNCT06320405

Observational

Reduction and Nonreduction Treatment of Displaced Pediatric Distal Radius Fractures (Peds-DRIFT Trial - Distal Radius Interventions for Fracture Treatment)

This protocol describes a multicenter, prospective randomized superiority trial with a patient preference cohort comparing functional outcomes between children…

Fracture Distal Radius

Estimated

~$10 – $750

Actual pay is set by the research site.

Ann & Robert H Lurie Children's Hospital of ChicagoNCT05131685

Phase 1

A Phase 1 Dose Escalation and Expansion Study of XB628 as a Single Agent and in Combination With Zanzalintinib in Participants With Advanced or Metastatic Solid Tumors

This study consists of a Dose-Escalation stage and a Dose Expansion stage. The primary purpose of the dose escalation stage is to determine the maximum tolerat…

Solid TumorAdvanced Solid TumorMetastatic Solid Tumor+1 more

Estimated

~$150 – $4,500

Actual pay is set by the research site.

ExelixisNCT06952010

OMNIPHYS: A Prospective Multimodal Longitudinal Study of AI-Enabled Physiologic State Modeling and Early Detection of Clinical Deterioration

The OMNIPHYS study will investigate whether multimodal ultrasound and other routinely collected clinical and physiologic data can be combined with artificial i…

Heart FailureCardiomyopathiesPulmonary Hypertension+29 more

Estimated

~$10 – $1,050

Actual pay is set by the research site.